Who’s Hired? Alvotech Brings In New Quality Chief
As Lupin Appoints A CSO From Hikma, Which Sees Multiple Executives Move On
Executive Summary
Alvotech has appointed a new chief quality officer in the wake of manufacturing deficiencies being identified by the US FDA. Meanwhile, multiple executives have departed from Hikma’s management team, with one joining Lupin as chief scientific officer.
You may also be interested in...
Who’s Hired? Alvotech Names New COO After Refiling Adalimumab
Alvotech has appointed a fresh chief operating officer as it continues to pursue a US approval for its adalimumab biosimilar. Meanwhile, Strides Pharma Science’s strategy head has left the company and Nick Haggar has joined Biocon’s board, while US association the AAM has also welcomed new staff.
After Latest Adalimumab CRL, Alvotech Gets Another New Quality Chief
Six months after replacing its chief quality officer, biosimilars specialist Alvotech has again appointed a new head of quality, in the wake of the latest US FDA knockback for its AVT02 proposed adalimumab biosimilar rival to Humira.
Alvotech Switches CEO And Takes COO From Teva
Major leadership changes are being made at the top of Alvotech, with founder Robert Wessman stepping in to replace Mark Levick as CEO at the same time as Teva’s former head of global R&D, Hafrun Fridriksdottir, becomes COO of the biosimilars developer.